Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study

Peter Bager(Statens Serum Institut), Arieh S. Cohen(Statens Serum Institut), Raphael N. Sieber(Statens Serum Institut), Ram Benny Dessau(University of Southern Denmark), Jan Wohlfahrt(Statens Serum Institut), Jon Gitz Holler, Lone Simonsen(Roskilde University), Palle Valentiner‐Branth(Statens Serum Institut), John Coia(Stobhill Hospital), Jannik Fonager(Statens Serum Institut), Henrik Ullum(Statens Serum Institut), Caroline Hjorth Espensen, Martin Friis, Karina Lauenborg Møller, Frederikke Kristensen Lomholt(Statens Serum Institut), Marc Stegger(Statens Serum Institut), Zitta Barrella Harboe(Statens Serum Institut), Marianne Karakis(Statens Serum Institut), Kåre Mølbak(Statens Serum Institut), Marianne Voldstedlund(Statens Serum Institut), Sofie Marie Edslev(Statens Serum Institut), Maria Overvad(Statens Serum Institut), Rebecca Legarth(Statens Serum Institut), Ellinor Marving(Statens Serum Institut), Camilla Holten Møller(Statens Serum Institut), Louise Hallundbæk, Mie Agermose Gram(Statens Serum Institut), Morten Rasmussen, Maarten van Wijhe, Nikolai Kirkby(Statens Serum Institut), Anna Cäcilia Ingham, Tyra Grove Krause(Statens Serum Institut), Thea Kølsen Fischer, Nicolai Balle Larsen(Statens Serum Institut), Robert Skov(Statens Serum Institut), Ea Sofie Marmolin, Troels Lillebæk(Statens Serum Institut), Thomas Vognbjerg Sydenham(University of Southern Denmark), Marianne Kragh Thomsen(Aarhus University), Katja Spieß(University of Copenhagen), Anders Fomsgaard(Statens Serum Institut), Sophie Gubbels(Statens Serum Institut), Samir Bhatt(University of Copenhagen), Stefan S. Olsen(Statens Serum Institut), David Fuglsang-Damgaard, Mette Pinholt(Hvidovre Hospital), Caroline Klint Johannesen(Nordsjællands Hospital)
The Lancet Infectious Diseases
April 22, 2022
Cited by 218


Related Papers